MetLife (MET) Director Daniel Glaser Receives 10-Share Award

What Happened
Daniel S. Glaser, a director of MetLife, received 10 shares of MetLife common stock on 2026-09-08 at an imputed price of $95.50 per share, for a total value of $955. The filing records this as an acquisition/award (code A) tied to deferred compensation rather than an open-market purchase.

Key Details

• Transaction date and price: 2026-09-08 — 10 shares at $95.50 each (total $955).
• Filing date / timeliness: Form 4 filed 2026-09-10 (two days after the transaction); filing appears timely.
• Shares owned after transaction: Not specified in the summary filing.
• Footnotes:
  • F1: Imputed reinvestment of dividends on deferred shares under the MetLife Deferred Compensation Plan for Non-Management Directors (deferred shares are payable shares the director deferred).
  • F2: These shares are held in a GRAT (Grantor Retained Annuity Trust).
• Transaction type: Award/acquisition via deferred compensation (code A).

Context
This was an imputed dividend reinvestment/award tied to a deferred compensation arrangement for non-management directors and is typically a routine administrative transaction, not a market-timed purchase or sale. The dollar amount is small ($955), so it’s unlikely to signal a material change in insider sentiment.